Details of the Drug

General Information of Drug (ID: DMM7HKG)

Drug Name
PR-006
Indication
Disease Entry ICD 11 Status REF
Frontotemporal dementia 6D83 Phase 1/2 [1]
Drug Type
Gene therapy
Cross-matching ID
TTD ID
D5C4YE

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Progranulin (PGRN) TT4LM0E GRN_HUMAN Not Available [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT04408625) A Phase 1/2 Ascending Dose Study to Evaluate the Safety and Effects on Progranulin Levels of LY3884963 in Patients With Fronto-Temporal Dementia With Progranulin Mutations (FTD-GRN). U.S.National Institutes of Health.
2 Clinical pipeline report, company report or official report of Prevail Therapeutics